The impact on incident tuberculosis by kidney function impairment status

Shu, CC., Wei, YF., Yeh, YC. et al. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res 21, 51 (2020). https://doi.org/10.1186/s12931-020-1294-5

  • LTBI screening is highly recommended for patients with end-stage renal disease on long-term dialysis; however, the TB risk in patients with chronic kidney disease (CKD) not requiring dialysis remains less clear.
  • With the worldwide increase in CKD burden, understanding its correlation with TB infection is gaining importance.
  • The study focused on patients aged ≥20 years from January 2008 to December 2013, using serum creatinine data to estimate kidney function via the MDRD equation, categorizing CKD into stages based on eGFR values.
  • Exclusions were made for patients with active tuberculosis prior to or shortly after initial kidney function assessment and those with short follow-up periods.
  • Incidence of TB among participants was analyzed by average number per 100,000 person-years, with the male gender comprising about 45.3% of the study group.
  • Advanced stages of CKD showed a significant increase in comorbidities such as CHF, stroke, DM, and SLE, whereas obesity was less common in patients with worse kidney function.
  • Older males with underlying diseases like pulmonary disease, GERD, cancer, heart failure, cirrhosis, diabetes, and autoimmune diseases were more likely to develop TB.
  • Incidence and hazard ratios (HR) for TB increased with declining kidney function, especially from CKD stage 3 onwards, suggesting a higher TB risk as kidney function worsens.
  • Although TB risk in CKD stage 5 was approximately two-fold with a 1.4-fold HR compared to those on long-term dialysis, overlapping confidence intervals indicate uncertainty.
  • Recommendations are made for TB prevention to target patients with CKD stage 3 or higher, in line with WHO guidelines for active LTBI screening in dialysis patients.

    •  

    Comments

    Post a Comment

    Popular posts from this blog

    Nutritional status in patients with TB and DM

    Patel, D.G., Baral, T., Kurian, S.J., Malakapogu, P., Saravu, K. and Miraj, S.S., 2024. Nutritional status in patients with tuberculosis and diabetes mellitus: A comparative observational study.  Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ,  35 , p.100428. Cardiovascular disease prevalence was highest in the DM group, followed by the TB-DM group. Anaemia was more prevalent in the TB-DM group. Smoking and alcohol use were most common in the TB group, followed by the TB-DM group. See also: TB and kidney function impairment In the TB-DM group, HbA1c levels indicated poor diabetic control (10.47%), higher than in the DM group (8.17%). FBS was also above normal in the TB-DM group, followed by the DM group. Although there were no significant differences in nutritional parameters like albumin, globulin, and total proteins, vitamin B12 levels were highest in the TB-DM group. Notably, 95.83% of patients in the TB-DM group had HbA1c > 6.5, with similarly high FBS and RB
    Read more

    Impact of diabetes on tuberculosis and MDRTB susceptibility

    There is a significant association between diabetes mellitus (DM) and multidrug-resistant tuberculosis (MDR-TB). TB patients without DM have a lower risk of developing MDR-TB compared to those with DM. Factors contributing to MDR-TB emergence in TB patients with DM include: Impaired immune function Altered microbial genomics Uncontrolled glucose levels, increasing susceptibility to MDR-TB Compromised phagocytic activity and reduced chemotactic response Increased oxidative species and microbe proliferation Altered drug disposition Higher likelihood of non-adherence to treatment TB patients with DM also experience higher treatment failure rates compared to those without DM. Most information on these associations is based on self-reported data or patient health records, which may introduce assessment errors Rehman Au, Khattak M, Mushtaq U, Latif M, Ahmad I, Rasool MF, Shakeel S, Hayat K, Hussain R, Alhazmi GA, Alshomrani AO, Alalawi MI, Alghamdi S, Imam MT, Almarzoky Abuhussain SS, Khayya
    Read more

    Scientific advances and the end of tuberculosis

    Reid, M., Agbassi, Y.J.P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D. and Churchyard, G., 2023. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis.  The Lancet ,  402 (10411), pp.1473-1498. Progress toward ending tuberculosis varies greatly across countries, with some achieving substantial improvements and others making minimal progress. Key challenges include frail health systems, underinvestment, and reliance on one-size-fits-all approaches. Insufficient case finding and diagnosis remain the most significant issues in high-burden countries, where only 38% of all tuberculosis cases were tested with WHO-recommended rapid molecular diagnostics in 2021. Two-thirds of tuberculosis deaths occurred in just eight countries, with over half of these in India, Indonesia, and Nigeria. Despite these challenges, some sub-Saharan African countries have seen improvements in tubercul
    Read more